Updates in AxSpA from EULAR 2025 include 3-year data for bimekizumab, definition of difficult-to-manage subgroups, ...

Rheumatoid arthritis and spondyloarthritis are long-lasting inflammatory diseases that gradually wear down joints. While ...

Expansion of treatment options for axial spondyloarthritis (axSpA) has brought attention to documented delays in diagnosis, which is estimated to be an average of 6.7 years worldwide ...

Inspired by feedback from the hidradenitis suppurativa (HS) community, the campaign aims to raise awareness of BIMZELX and features a broad range of ...

People with back pain face some uncertainty in diagnosis that is unsettling to patients and physicians alike. But once a diagnosis of axial spondyloarthritis (axSpA) is made, concerns often shift ...

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

The study, published Feb. 13 in Gut Microbes, also demonstrated that the gut microbiota of people with Crohn's and axial spondyloarthritis ... affects more than half a million Americans and causes ...

AS can also involve gastrointestinal symptoms and, in some cases, chronic inflammatory bowel diseases (IBD), such as Crohn’s disease or ulcerative colitis , may be present.

This review discusses the features of oligoarticular, polyarticular, systemic, and psoriatic JIA and enthesitis-related ...

A significant percentage of patients with SSc first present with non-RP symptoms — most commonly puffy fingers/hands — and are associated with more severe disease.